• Home | Global Data CRO
  • Our Company
    • About Us
    • Executive Leadership
    • Board of Directors
    • Scientific Advisory Board
    • Global Leaders
    • Working with MMS
    • Certifications
  • Services
    • Regulatory Affairs
      • Regulatory Affairs Services
      • Regulatory Strategy Consulting
      • Regulatory Affairs Management
      • Regulatory Operations
    • Data Management and Biostatistics
    • Regulatory and Medical Writing
    • Transparency Services
      • Transparency and Disclosure Services
      • REGISTRATION AND RESULTS DISCLOSURES
      • Data and Document Anonymization
      • LAY SUMMARIES
    • Quality and Compliance services
    • Drug Safety and Pharmacovigilance
    • Rare Disease
    • Quality Control Services
    • Project Advisory Services
    • Data Science
  • Technology
    • Datacise
    • Automatiqc
    • PVantage
    • Technology Implementation
    • SmartStart Document Templates
  • Functional Services (FSP)
  • Webinars
  • News and Media
  • MMS Blog
  • Careers
    • MMS Careers
    • Opportunities
    • MMS Experience
    • MMS Culture
    • Global Benefits
    • FAQ
  • Learning
  • Contact Us
MMS Holdings
FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines

FDA Advisory Committee Meeting Held to Discuss Important Topics Surrounding COVID-19 Vaccines

by Avery Zimmerman | Oct 27, 2020 | Blog

The US Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) met on Thursday, October 22, 2020, to discuss the development, authorization, and/or licensure of vaccines to prevent COVID-19. The committee heard from...
Why COVID-19 testing devices require a high level of specificity

Why COVID-19 testing devices require a high level of specificity

by Avery Zimmerman | Jul 10, 2020 | Blog

  Note: To use the dashboard, read the article below, then click the arrows on the dashboard to enter full screen mode. Use the dashboard to find the prevalence of COVID-19 among tested individuals within your region of interest. Then, adjust the sensitivity,...
Helping to Accelerate the Search for Solutions to the COVID-19 Crisis

Helping to Accelerate the Search for Solutions to the COVID-19 Crisis

by Avery Zimmerman | Jun 11, 2020 | News

The full article can be read on the IBM Watson Health website. An excerpt of the article is below.  The novel coronavirus (COVID-19) pandemic is an unprecedented crisis that has galvanized the global scientific community around the search for a viable vaccine and...
IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment

IGY Life Sciences Partners with MMS Holdings to Develop Novel COVID-19 Antibody Treatment

by Avery Zimmerman | Jun 9, 2020 | News

THUNDER BAY, ONTARIO (June 09, 2020) — IGY Life Sciences today announced it will be collaborating with clinical data and regulatory experts, MMS Holdings (MMS), to further the development of IgY-110, an anti-CoV-2 therapeutic antibody with a focus on a nasal spray...
With Safety, Urgency, and Innovation: How an Award-Winning CRO Operates During COVID-19

With Safety, Urgency, and Innovation: How an Award-Winning CRO Operates During COVID-19

by Avery Zimmerman | Apr 28, 2020 | Blog

The COVID-19 pandemic has impacted the way many pharmaceutical, biotech, and CRO companies are working, rewarding flexibility and agile resourcing and operating models. In this expert insights blog, we sit down (virtually) with Kelly J. Hill, Executive Director,...
Page 1 of 212»

Recent Posts

  • Award-Winning Data CRO Expands Executive Leadership to Support Company’s Next Stage of Growth
  • What is FDA’s Project Renewal? The Modernization of Decades Old Oncology Drug Labels
  • FDA Updates IND Expanded Access Guidance for Industry
  • What is Regulatory Information Management System (RIMS)?
  • Expanded Access to IND – Full Question and Answer in Draft Guidance

Tags

biostatistics Careers clinical research clinical study reports clinical trial disclosure clinical trials clinical trial transparency Compliance conference COVID-19 CRO data management data privacy data science decentralized clinical trials diversity and inclusion drug development eCOA & ePro EMA FDA Functional Service Provider (FSP) GXP auditing Health Analytics Collective innovation Lay summaries leadership medical writing MMS Academy NDA submission News Orphan Drug Designation Applications PDUFA VII pharmacovigilance PhUSE plain language summary Policy 0070 Praxis bioresearch quality and compliance quality control rare disease real world data regulatory affairs regulatory operations statistical programming transparency